Off-the-Shelf Personalized Peptide Cancer Immunotherapies Technology

PEPI Panel – A unique approach for personalized cancer immunotherapy generation.  Our Peptide Library (PEPI Panel) currently contains 3,286 proprietary, immunogenic peptide fragments from 184 tumor antigens associated with 19 cancer indications that induce immune responses in the largest subpopulation of subjects, based on HLA genotype (both class I and II) of 16,000 subjects. PEPI Panel approach guides selection of 12 individual peptides tailored to the tumor type and HLA genotype of patients from a warehouse of off-the-shelf peptides permitting rapid, efficient manufacture of a personalized immunotherapy. Treos’ differentiated and scalable approach provides substantial competitive advantage over all other approaches in the personalized cancer immunotherapy field, and offers an exclusive opportunity to produce personalized products faster and cheaper.